Supplement-To-Drug Applications Look Like The Next Wave To Some Experts
This article was originally published in The Tan Sheet
Executive Summary
FDA's dietary supplement good manufacturing practices, while imposed to help assure safe nutritionals reach the market, are creating costs that could drive more firms to file new drug applications for natural products, according to a pair of regulatory experts